English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine Clinical Trials
아방스 클리니컬, 바이오 코리아 2021에서 업계 조사 결과 발표
May 28, 2021 07:00 HKT
Avance Clinical Releases Industry Survey Results at BIO Korea 2021
May 27, 2021 10:00 HKT
애질렉스 바이오랩스, 임상 시험 목적의 염증 및 면역학 디콘볼루션 위해 엔드포인트 뉴스와 협업
May 24, 2021 08:00 HKT
Agilex Biolabs与Endpoints新闻合作开展消卷积炎症和免疫学临床试验
May 21, 2021 13:00 HKT
Agilex Biolabs與Endpoints新聞合作開展消卷積炎症和免疫學臨床試驗
May 21, 2021 13:00 HKT
Agilex Biolabs Partners with Endpoints News on Deconvoluting Inflammation and Immunology for Clinical Trials
May 21, 2021 11:00 HKT
Agilex Biolabs' Toxicology Tapped for SARS-CoV-2 Vaccine Research
May 17, 2021 21:00 HKT
Avance Clinical Expands Gene Technology Clinical Trial Services to Meet $17.4 billion Market Demand
May 07, 2021 00:00 HKT
애질렉스 바이오랩스, BNC210에서 PK 결과 얻은 바이오노믹스를 축하
May 01, 2021 10:00 HKT
Agilex Biolabs祝贺Bionomics Limited BNC210 PK上的结果
Apr 30, 2021 14:00 HKT
Agilex Biolabs祝賀Bionomics Limited BNC210 PK上的結果
Apr 30, 2021 14:00 HKT
Agilex Biolabs Congratulates Bionomics Limited on BNC210 PK Results
Apr 30, 2021 13:00 HKT
애질렉스 바이오랩스와 B2S 생명과학, 임상실험용 면역 분석법 바이오 분석에 대한 중요 주제 공유
Apr 29, 2021 08:00 HKT
Agilex Biolabs and B2S Life Sciences on Immunoassay Bioanalysis for Clinical Trials
Apr 29, 2021 04:00 HKT
Agilex Biolabs收购领先的Biolab TetraQ作为APAC扩展计划的一部分
Apr 07, 2021 15:00 HKT
Agilex Biolabs收購領先的Biolab TetraQ作為APAC擴展計劃的一部分
Apr 07, 2021 15:00 HKT
TrialWire launches StudyBoost, the Clinical Trial Insurance Plan
Mar 24, 2021 05:00 HKT
New benchmark set to deliver optimal osteoporosis care throughout Asia Pacific
Jan 28, 2021 07:00 HKT
Penanda aras baru yang akan memberikan penjagaan osteoporosis yang optimum ke seluruh Asia Pasifik
Jan 28, 2021 01:30 HKT
최적의 골다공증 케어를 위한 새로운 아시아태평양 벤치마크 설정
Jan 28, 2021 01:30 HKT
<< Previous  Next >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: